The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Circulating Tumor Cells (CTC)-Global Market Insights and Sales Trends 2025
Synopsis
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global Circulating Tumor Cells (CTC) market size is expected to reach US$ 4297.5 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Circulating Tumor Cells (CTC) in various end use industries. The expanding demands from the Tumorigenesis Research, Emt Biomarkers Development, Cancer Stem Cell Research and Others, are propelling Circulating Tumor Cells (CTC) market. Ex-Vivo Positive Selection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the In-Vivo Positive Selection segment is estimated at % CAGR for the next seven-year period.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circulating Tumor Cells (CTC) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circulating Tumor Cells (CTC) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circulating Tumor Cells (CTC) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circulating Tumor Cells (CTC) covered in this report include AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech and Nanostring Technologies, etc.
The global Circulating Tumor Cells (CTC) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Global Circulating Tumor Cells (CTC) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circulating Tumor Cells (CTC) market, Segment by Type:
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Global Circulating Tumor Cells (CTC) market, by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Circulating Tumor Cells (CTC) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global Circulating Tumor Cells (CTC) market size is expected to reach US$ 4297.5 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Circulating Tumor Cells (CTC) in various end use industries. The expanding demands from the Tumorigenesis Research, Emt Biomarkers Development, Cancer Stem Cell Research and Others, are propelling Circulating Tumor Cells (CTC) market. Ex-Vivo Positive Selection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the In-Vivo Positive Selection segment is estimated at % CAGR for the next seven-year period.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circulating Tumor Cells (CTC) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circulating Tumor Cells (CTC) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circulating Tumor Cells (CTC) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circulating Tumor Cells (CTC) covered in this report include AdnaGen, Apocell, Biocep, Canopus Bioscience, Creatv Microtech, Ikonisys, IV Diagnostics, Miltenyi Biotech and Nanostring Technologies, etc.
The global Circulating Tumor Cells (CTC) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Global Circulating Tumor Cells (CTC) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circulating Tumor Cells (CTC) market, Segment by Type:
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Global Circulating Tumor Cells (CTC) market, by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Circulating Tumor Cells (CTC) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Circulating Tumor Cells (CTC)
1.1 Circulating Tumor Cells (CTC) Market Overview
1.1.1 Circulating Tumor Cells (CTC) Product Scope
1.1.2 Circulating Tumor Cells (CTC) Market Status and Outlook
1.2 Global Circulating Tumor Cells (CTC) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Circulating Tumor Cells (CTC) Market Size by Region (2018-2029)
1.4 Global Circulating Tumor Cells (CTC) Historic Market Size by Region (2018-2023)
1.5 Global Circulating Tumor Cells (CTC) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Circulating Tumor Cells (CTC) Market Size (2018-2029)
1.6.1 North America Circulating Tumor Cells (CTC) Market Size (2018-2029)
1.6.2 Europe Circulating Tumor Cells (CTC) Market Size (2018-2029)
1.6.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2018-2029)
1.6.4 Latin America Circulating Tumor Cells (CTC) Market Size (2018-2029)
1.6.5 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2018-2029)
2 Circulating Tumor Cells (CTC) Market by Type
2.1 Introduction
2.1.1 Ex-Vivo Positive Selection
2.1.2 In-Vivo Positive Selection
2.1.3 Negative Selection
2.1.4 Microchips & Single Spiral Micro Channel
2.2 Global Circulating Tumor Cells (CTC) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2018-2023)
2.2.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Circulating Tumor Cells (CTC) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Circulating Tumor Cells (CTC) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Circulating Tumor Cells (CTC) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Circulating Tumor Cells (CTC) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Circulating Tumor Cells (CTC) Revenue Breakdown by Type (2018-2029)
3 Circulating Tumor Cells (CTC) Market Overview by Application
3.1 Introduction
3.1.1 Tumorigenesis Research
3.1.2 Emt Biomarkers Development
3.1.3 Cancer Stem Cell Research
3.1.4 Others
3.2 Global Circulating Tumor Cells (CTC) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2018-2023)
3.2.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Circulating Tumor Cells (CTC) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Circulating Tumor Cells (CTC) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Circulating Tumor Cells (CTC) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Circulating Tumor Cells (CTC) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Circulating Tumor Cells (CTC) Revenue Breakdown by Application (2018-2029)
4 Circulating Tumor Cells (CTC) Competition Analysis by Players
4.1 Global Circulating Tumor Cells (CTC) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2022)
4.3 Date of Key Players Enter into Circulating Tumor Cells (CTC) Market
4.4 Global Top Players Circulating Tumor Cells (CTC) Headquarters and Area Served
4.5 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
4.6 Competitive Status
4.6.1 Circulating Tumor Cells (CTC) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AdnaGen
5.1.1 AdnaGen Profile
5.1.2 AdnaGen Main Business
5.1.3 AdnaGen Circulating Tumor Cells (CTC) Products, Services and Solutions
5.1.4 AdnaGen Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.1.5 AdnaGen Recent Developments
5.2 Apocell
5.2.1 Apocell Profile
5.2.2 Apocell Main Business
5.2.3 Apocell Circulating Tumor Cells (CTC) Products, Services and Solutions
5.2.4 Apocell Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.2.5 Apocell Recent Developments
5.3 Biocep
5.3.1 Biocep Profile
5.3.2 Biocep Main Business
5.3.3 Biocep Circulating Tumor Cells (CTC) Products, Services and Solutions
5.3.4 Biocep Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.3.5 Canopus Bioscience Recent Developments
5.4 Canopus Bioscience
5.4.1 Canopus Bioscience Profile
5.4.2 Canopus Bioscience Main Business
5.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Products, Services and Solutions
5.4.4 Canopus Bioscience Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.4.5 Canopus Bioscience Recent Developments
5.5 Creatv Microtech
5.5.1 Creatv Microtech Profile
5.5.2 Creatv Microtech Main Business
5.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Products, Services and Solutions
5.5.4 Creatv Microtech Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.5.5 Creatv Microtech Recent Developments
5.6 Ikonisys
5.6.1 Ikonisys Profile
5.6.2 Ikonisys Main Business
5.6.3 Ikonisys Circulating Tumor Cells (CTC) Products, Services and Solutions
5.6.4 Ikonisys Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.6.5 Ikonisys Recent Developments
5.7 IV Diagnostics
5.7.1 IV Diagnostics Profile
5.7.2 IV Diagnostics Main Business
5.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Products, Services and Solutions
5.7.4 IV Diagnostics Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.7.5 IV Diagnostics Recent Developments
5.8 Miltenyi Biotech
5.8.1 Miltenyi Biotech Profile
5.8.2 Miltenyi Biotech Main Business
5.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Products, Services and Solutions
5.8.4 Miltenyi Biotech Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.8.5 Miltenyi Biotech Recent Developments
5.9 Nanostring Technologies
5.9.1 Nanostring Technologies Profile
5.9.2 Nanostring Technologies Main Business
5.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Products, Services and Solutions
5.9.4 Nanostring Technologies Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.9.5 Nanostring Technologies Recent Developments
5.10 Rarecells Diagnostics
5.10.1 Rarecells Diagnostics Profile
5.10.2 Rarecells Diagnostics Main Business
5.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Products, Services and Solutions
5.10.4 Rarecells Diagnostics Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.10.5 Rarecells Diagnostics Recent Developments
5.11 Vitatex
5.11.1 Vitatex Profile
5.11.2 Vitatex Main Business
5.11.3 Vitatex Circulating Tumor Cells (CTC) Products, Services and Solutions
5.11.4 Vitatex Circulating Tumor Cells (CTC) Revenue (US$ Million) & (2018-2023)
5.11.5 Vitatex Recent Developments
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Circulating Tumor Cells (CTC) Market Dynamics
11.1 Circulating Tumor Cells (CTC) Industry Trends
11.2 Circulating Tumor Cells (CTC) Market Drivers
11.3 Circulating Tumor Cells (CTC) Market Challenges
11.4 Circulating Tumor Cells (CTC) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
